239 related articles for article (PubMed ID: 10029444)
1. Decreased immunoexpression of prostate inhibin peptide in prostatic carcinoma: a study with monoclonal antibody.
Zhang PJ; Driscoll DL; Lee HK; Nolan C; Velagapudi SR
Hum Pathol; 1999 Feb; 30(2):168-72. PubMed ID: 10029444
[TBL] [Abstract][Full Text] [Related]
2. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer antigen-1 as a potential novel marker for prostate cancer.
Liu BQ; Wu YD; Li PH; Wei JX; Zhang T; Liu RL
Asian J Androl; 2007 Nov; 9(6):821-6. PubMed ID: 17968469
[TBL] [Abstract][Full Text] [Related]
4. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".
He H; Magi-Galluzzi C; Li J; Carver P; Falzarano S; Smith K; Rubin MA; Zhou M
Am J Surg Pathol; 2011 Apr; 35(4):608-14. PubMed ID: 21383613
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
[TBL] [Abstract][Full Text] [Related]
7. Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate.
Lee HK; Driscoll D; Asch H; Asch B; Zhang PJ
Prostate; 1999 Jun; 40(1):14-9. PubMed ID: 10344719
[TBL] [Abstract][Full Text] [Related]
8. [The morphogenesis of cancer of the prostate (immunohistochemical research)].
Vorobĭova LR
Lik Sprava; 1998 May; (3):87-90. PubMed ID: 9695575
[TBL] [Abstract][Full Text] [Related]
9. Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients.
Lehnigk U; Zimmermann U; Woenckhaus C; Giebel J
Histol Histopathol; 2005 Jul; 20(3):673-80. PubMed ID: 15944914
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic vessel density in the normal-looking columnar epithelium adjacent to and distant from prostatic intraepithelial neoplasia and prostate cancer assessed in whole-mount sections.
Longatto-Filho A; Malheiro LF; Milanezi F; Pinheiro C; Baltazar F; Schmitt FC; Montironi R
Anal Quant Cytol Histol; 2009 Oct; 31(5):269-75. PubMed ID: 20701093
[TBL] [Abstract][Full Text] [Related]
11. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features.
Gabal SM; Habib FM; Helmy DO; Ibrahim MF
J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287
[TBL] [Abstract][Full Text] [Related]
12. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
Coogan CL; Bostwick DG; Bloom KJ; Gould VE
Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
[TBL] [Abstract][Full Text] [Related]
13. Expression of NGF, GDNF and MMP-9 in prostate carcinoma.
Baspinar S; Bircan S; Ciris M; Karahan N; Bozkurt KK
Pathol Res Pract; 2017 May; 213(5):483-489. PubMed ID: 28237042
[TBL] [Abstract][Full Text] [Related]
14. [Expressions of TFF1 and TFF3 in prostate cancer and prostatic intraepithelial neoplasia and their clinical significance].
Liu M; Jin RS
Zhonghua Nan Ke Xue; 2015 Apr; 21(4):315-9. PubMed ID: 26027097
[TBL] [Abstract][Full Text] [Related]
15. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of IGBFB2 is a marker for malignant transformation in prostate epithelium.
Richardsen E; Ukkonen T; Bjørnsen T; Mortensen E; Egevad L; Busch C
Virchows Arch; 2003 Apr; 442(4):329-35. PubMed ID: 12684767
[TBL] [Abstract][Full Text] [Related]
17. Prostate inhibin peptide (PIP) in prostate cancer: a comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP).
Garde SV; Sheth AR; Venkatesan VM; Panchal CJ; Porter AT; Grignon DJ
Cancer Lett; 1994 Apr; 78(1-3):11-7. PubMed ID: 7514089
[TBL] [Abstract][Full Text] [Related]
18. Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue.
Jonmarker S; Glaessgen A; Culp WD; Pisa P; Lewensohn R; Ekman P; Valdman A; Egevad L
APMIS; 2008 Jun; 116(6):491-8. PubMed ID: 18754323
[TBL] [Abstract][Full Text] [Related]
19. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
[TBL] [Abstract][Full Text] [Related]
20. Trefoil factor 3 is overexpressed in human prostate cancer.
Garraway IP; Seligson D; Said J; Horvath S; Reiter RE
Prostate; 2004 Nov; 61(3):209-14. PubMed ID: 15368472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
